1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 CIS PROLINE - PRO 75 MODEL 1 CIS PROLINE - PRO 75 MODEL 2 CIS PROLINE - PRO 75 MODEL 3 CIS PROLINE - PRO 75 MODEL 4 CIS PROLINE - PRO 75 MODEL 5 CIS PROLINE - PRO 75 MODEL 6 CIS PROLINE - PRO 75 MODEL 7 CIS PROLINE - PRO 75 MODEL 8 CIS PROLINE - PRO 75 MODEL 9 CIS PROLINE - PRO 75 MODEL 10 CIS PROLINE - PRO 75 MODEL 11 CIS PROLINE - PRO 75 MODEL 12 CIS PROLINE - PRO 75 MODEL 13 CIS PROLINE - PRO 75 MODEL 14 CIS PROLINE - PRO 75 MODEL 15 CIS PROLINE - PRO 75 MODEL 16 CIS PROLINE - PRO 75 MODEL 17 CIS PROLINE - PRO 75 MODEL 18 CIS PROLINE - PRO 75 MODEL 19 CIS PROLINE - PRO 75 MODEL 20 CIS PROLINE - PRO 75 MODEL 21 CIS PROLINE - PRO 75 MODEL 22 CIS PROLINE - PRO 75 MODEL 23 CIS PROLINE - PRO 75 MODEL 24 CIS PROLINE - PRO 75 MODEL 25 CIS PROLINE - PRO 75 MODEL 26 CIS PROLINE - PRO 75 MODEL 27 CIS PROLINE - PRO 75 MODEL 28 CIS PROLINE - PRO 75 MODEL 29 CIS PROLINE - PRO 75 MODEL 30 CIS PROLINE - PRO 75 MODEL 31 CIS PROLINE - PRO 75 MODEL 32 CIS PROLINE - PRO 75 MODEL 33 CIS PROLINE - PRO 75 MODEL 34 CIS PROLINE - PRO 75 MODEL 35 CIS PROLINE - PRO 75 MODEL 36 CIS PROLINE - PRO 75 MODEL 37 CIS PROLINE - PRO 75 MODEL 38 CIS PROLINE - PRO 75 MODEL 39 CIS PROLINE - PRO 75 MODEL 40 Clore, G.M. Qin, J. Gronenborn, A.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 2 503 522 10.1016/S0969-2126(00)00051-4 7922028 The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin. 1994 10.2210/pdb1tru/pdb pdb_00001tru 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 11624.190 THIOREDOXIN 1 man polymer 18.015 water 7 nat water no no MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDAQDVASEAEVKATPTFQFF KKGQKVGEFSGANKEKLEATINELV MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDAQDVASEAEVKATPTFQFF KKGQKVGEFSGANKEKLEATINELV A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1994-09-30 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1994-05-10 REL HOH water 40 THE 3D STRUCTURE OF OXIDIZED HUMAN THIOREDOXIN IN SOLUTION BY NMR IS BASED ON 3018 EXPERIMENTAL RESTRAINTS COMPRISING: 2649 STRUCTURE USEFUL INTERPROTON DISTANCE RESTRAINTS; 34 RESTRAINTS FOR 17 H-BONDS INVOLVING 7 TIGHTLY BOUND WATER MOLECULES; 42 RESTRAINTS FOR 21 BACKBONE HYDROGEN BONDS INVOLVING SLOWLY EXCHANGING AMIDE PROTONS; 278 TORSION ANGLE RESTRAINTS (104 PHI, 76 PSI, 78 CHI1 AND 20 CHI2); AND 91 HN-HALPHA THREE-BOND COUPLING CONSTANTS. A COMPLETE LIST OF EXPERIMENTAL RESTRAINTS AND 1H, 13C AND 15N ASSIGNMENTS HAVE BEEN DEPOSITED WITH THE PROTEIN DATA BANK. THE STRUCTURES ARE CALCULATED USING THE HYBRID METRIC MATRIX DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING METHOD DESCRIBED BY: NILGES, M., CLORE, G.M. & GRONENBORN, A.M. (1988) FEBS LETT 229, 317 - 324. ALL STRUCTURAL STATISTICS ARE GIVEN IN THE REFERENCE. THE RESTRAINED MINIMIZED AVERAGE STRUCTURE (SA)R IS PRESENTED IN PROTEIN DATA BANK ENTRY 1TRS. THIS IS OBTAINED BY FIRST AVERAGING THE COORDINATES OF THE INDIVIDUAL 40 DYNAMICAL SIMULATED ANNEALING SA STRUCTURES BEST FITTED TO RESIDUES 1 - 105, AND SUBJECTING THE RESULTING COORDINATES TO RESTRAINED MINIMIZATION. COLUMNS 61 - 65 OF THE COORDINATE RECORDS (THE B VALUE FIELD IN X-RAY STRUCTURES) IN THE MINIMIZED STRUCTURE (ENTRY 1TRS) GIVE THE AVERAGE RMS DIFFERENCE BETWEEN THE INDIVIDUAL SA STRUCTURES AND THE MEAN STRUCTURE. THE NUMBERS IN THIS FIELD OF THE INDIVIDUAL STRUCTURES (ENTRY 1TRU) HAVE NO MEANING. HOH 201 2 HOH HOH 201 A HOH 202 2 HOH HOH 202 A HOH 203 2 HOH HOH 203 A HOH 204 2 HOH HOH 204 A HOH 205 2 HOH HOH 205 A HOH 206 2 HOH HOH 206 A HOH 207 2 HOH HOH 207 A MET 1 n 1 MET 1 A VAL 2 n 2 VAL 2 A LYS 3 n 3 LYS 3 A GLN 4 n 4 GLN 4 A ILE 5 n 5 ILE 5 A GLU 6 n 6 GLU 6 A SER 7 n 7 SER 7 A LYS 8 n 8 LYS 8 A THR 9 n 9 THR 9 A ALA 10 n 10 ALA 10 A PHE 11 n 11 PHE 11 A GLN 12 n 12 GLN 12 A GLU 13 n 13 GLU 13 A ALA 14 n 14 ALA 14 A LEU 15 n 15 LEU 15 A ASP 16 n 16 ASP 16 A ALA 17 n 17 ALA 17 A ALA 18 n 18 ALA 18 A GLY 19 n 19 GLY 19 A ASP 20 n 20 ASP 20 A LYS 21 n 21 LYS 21 A LEU 22 n 22 LEU 22 A VAL 23 n 23 VAL 23 A VAL 24 n 24 VAL 24 A VAL 25 n 25 VAL 25 A ASP 26 n 26 ASP 26 A PHE 27 n 27 PHE 27 A SER 28 n 28 SER 28 A ALA 29 n 29 ALA 29 A THR 30 n 30 THR 30 A TRP 31 n 31 TRP 31 A CYS 32 n 32 CYS 32 A GLY 33 n 33 GLY 33 A PRO 34 n 34 PRO 34 A CYS 35 n 35 CYS 35 A LYS 36 n 36 LYS 36 A MET 37 n 37 MET 37 A ILE 38 n 38 ILE 38 A LYS 39 n 39 LYS 39 A PRO 40 n 40 PRO 40 A PHE 41 n 41 PHE 41 A PHE 42 n 42 PHE 42 A HIS 43 n 43 HIS 43 A SER 44 n 44 SER 44 A LEU 45 n 45 LEU 45 A SER 46 n 46 SER 46 A GLU 47 n 47 GLU 47 A LYS 48 n 48 LYS 48 A TYR 49 n 49 TYR 49 A SER 50 n 50 SER 50 A ASN 51 n 51 ASN 51 A VAL 52 n 52 VAL 52 A ILE 53 n 53 ILE 53 A PHE 54 n 54 PHE 54 A LEU 55 n 55 LEU 55 A GLU 56 n 56 GLU 56 A VAL 57 n 57 VAL 57 A ASP 58 n 58 ASP 58 A VAL 59 n 59 VAL 59 A ASP 60 n 60 ASP 60 A ASP 61 n 61 ASP 61 A ALA 62 n 62 ALA 62 A GLN 63 n 63 GLN 63 A ASP 64 n 64 ASP 64 A VAL 65 n 65 VAL 65 A ALA 66 n 66 ALA 66 A SER 67 n 67 SER 67 A GLU 68 n 68 GLU 68 A ALA 69 n 69 ALA 69 A GLU 70 n 70 GLU 70 A VAL 71 n 71 VAL 71 A LYS 72 n 72 LYS 72 A ALA 73 n 73 ALA 73 A THR 74 n 74 THR 74 A PRO 75 n 75 PRO 75 A THR 76 n 76 THR 76 A PHE 77 n 77 PHE 77 A GLN 78 n 78 GLN 78 A PHE 79 n 79 PHE 79 A PHE 80 n 80 PHE 80 A LYS 81 n 81 LYS 81 A LYS 82 n 82 LYS 82 A GLY 83 n 83 GLY 83 A GLN 84 n 84 GLN 84 A LYS 85 n 85 LYS 85 A VAL 86 n 86 VAL 86 A GLY 87 n 87 GLY 87 A GLU 88 n 88 GLU 88 A PHE 89 n 89 PHE 89 A SER 90 n 90 SER 90 A GLY 91 n 91 GLY 91 A ALA 92 n 92 ALA 92 A ASN 93 n 93 ASN 93 A LYS 94 n 94 LYS 94 A GLU 95 n 95 GLU 95 A LYS 96 n 96 LYS 96 A LEU 97 n 97 LEU 97 A GLU 98 n 98 GLU 98 A ALA 99 n 99 ALA 99 A THR 100 n 100 THR 100 A ILE 101 n 101 ILE 101 A ASN 102 n 102 ASN 102 A GLU 103 n 103 GLU 103 A LEU 104 n 104 LEU 104 A VAL 105 n 105 VAL 105 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N LYS 3 A N LYS 3 A O PHE 54 A O PHE 54 A N LEU 55 A N LEU 55 A O VAL 24 A O VAL 24 A N PHE 27 A N PHE 27 A O THR 76 A O THR 76 A O LYS 81 A O LYS 81 A N GLN 84 A N GLN 84 1 A A H H2 VAL HOH 52 207 1.27 1 A A HD21 H ASN LYS 93 96 1.29 2 A A H H2 VAL HOH 52 207 1.33 3 A A H H1 VAL HOH 52 207 1.28 5 A A H H2 VAL HOH 52 207 1.26 6 A A H H1 VAL HOH 52 207 1.28 6 A A H H2 ASP HOH 58 202 1.34 7 A A H H2 VAL HOH 52 207 1.27 8 A A H H1 VAL HOH 52 207 1.28 9 A A HD21 H ASN LYS 93 96 1.27 9 A A H H2 VAL HOH 52 207 1.28 11 A A H H2 VAL HOH 52 207 1.26 12 A A H H2 VAL HOH 52 207 1.28 13 A A H H2 VAL HOH 52 207 1.26 14 A A H H2 VAL HOH 52 207 1.27 15 A A H H1 VAL HOH 52 207 1.28 16 A A H H2 VAL HOH 52 207 1.27 17 A A H H2 VAL HOH 52 207 1.26 18 A A H H2 VAL HOH 52 207 1.28 19 A A H H2 VAL HOH 52 207 1.27 20 A A H H1 VAL HOH 52 207 1.30 21 A A H H1 VAL HOH 52 207 1.28 22 A A H H2 VAL HOH 52 207 1.28 22 A A HD21 H ASN LYS 93 96 1.28 23 A A H H2 VAL HOH 52 207 1.28 24 A A H H1 VAL HOH 52 207 1.30 25 A A H H2 VAL HOH 52 207 1.26 26 A A H H2 VAL HOH 52 207 1.28 27 A A H H2 VAL HOH 52 207 1.34 28 A A H H2 VAL HOH 52 207 1.27 29 A A H H2 VAL HOH 52 207 1.27 30 A A H H2 VAL HOH 52 207 1.27 32 A A H H1 VAL HOH 52 207 1.28 33 A A H H1 VAL HOH 52 207 1.28 34 A A H H2 VAL HOH 52 207 1.27 35 A A H H2 VAL HOH 52 207 1.26 36 A A H H1 VAL HOH 52 207 1.28 37 A A H H1 VAL HOH 52 207 1.27 38 A A H H2 VAL HOH 52 207 1.27 39 A A H H2 VAL HOH 52 207 1.29 40 A A H H2 VAL HOH 52 207 1.28 1 A PHE 41 -115.02 -70.63 1 A VAL 59 -63.32 6.81 1 A ALA 62 -104.47 53.37 1 A LYS 82 52.63 9.12 1 A ASN 93 -103.22 73.37 2 A PHE 41 -115.35 -70.59 2 A ASN 51 -98.93 31.09 2 A VAL 59 -63.53 6.24 2 A ALA 62 -104.44 53.31 3 A ASN 51 -99.42 30.31 3 A VAL 59 -62.44 4.98 3 A ALA 62 -105.02 54.39 3 A LYS 82 51.60 11.75 4 A PHE 41 -115.17 -70.04 4 A ASN 51 -98.35 32.08 4 A VAL 59 -63.35 7.71 4 A ALA 62 -103.53 54.40 4 A LYS 82 52.23 13.16 5 A PHE 41 -115.39 -71.16 5 A VAL 59 -63.01 6.87 5 A ALA 62 -101.79 50.45 5 A LYS 82 52.10 11.82 5 A GLU 88 -172.06 147.20 5 A ASN 93 -104.38 79.37 6 A PRO 40 -69.24 5.09 6 A LEU 45 -59.92 -9.96 6 A ASN 51 -99.73 33.18 6 A VAL 59 -63.48 8.58 6 A ALA 62 -102.87 52.30 6 A ALA 73 -151.79 85.94 6 A LYS 82 52.66 9.16 6 A ASN 93 -104.14 79.16 7 A PHE 41 -116.29 -71.49 7 A HIS 43 -65.94 0.05 7 A ASN 51 -98.96 32.67 7 A VAL 59 -63.43 7.02 7 A ALA 62 -104.17 52.21 7 A LYS 82 52.38 9.46 8 A VAL 59 -63.44 6.51 8 A ALA 62 -102.32 52.91 8 A LYS 82 52.51 9.74 9 A PHE 41 -115.23 -72.39 9 A ASN 51 -99.33 31.02 9 A VAL 59 -64.05 8.26 9 A ALA 62 -104.95 53.53 9 A LYS 82 52.29 9.40 9 A GLU 88 -171.15 144.75 9 A ASN 93 -105.92 79.87 10 A PHE 41 -115.67 -70.26 10 A VAL 59 -63.42 6.78 10 A ALA 62 -103.27 50.88 10 A GLU 70 39.21 46.68 10 A ALA 73 -151.50 85.66 10 A LYS 82 53.85 7.65 10 A GLU 88 -171.66 144.99 11 A PHE 41 -115.57 -70.45 11 A LEU 45 -59.98 -8.76 11 A ASN 51 -98.94 32.38 11 A VAL 59 -63.53 7.88 11 A ALA 62 -103.58 53.45 11 A LYS 82 54.21 5.53 11 A ASN 93 -104.79 79.92 12 A PRO 40 -69.73 2.56 12 A PHE 41 -115.63 -71.67 12 A ASN 51 -99.23 32.16 12 A VAL 59 -63.59 4.58 12 A ALA 62 -103.11 48.48 12 A LYS 82 51.94 10.08 12 A GLU 88 -172.08 146.41 13 A PRO 40 -69.95 5.66 13 A PHE 41 -115.68 -70.17 13 A VAL 59 -63.18 5.57 13 A ALA 62 -102.81 51.46 13 A LYS 82 51.85 12.79 13 A GLU 88 -171.32 148.91 13 A ASN 93 -105.27 78.34 14 A ASN 51 -99.23 33.25 14 A VAL 59 -63.45 6.82 14 A ALA 62 -103.44 57.80 14 A LYS 82 52.33 8.46 14 A GLU 88 -171.92 146.46 14 A ALA 92 -80.04 49.16 14 A ASN 93 -104.72 78.08 15 A PHE 41 -115.73 -70.53 15 A VAL 59 -63.50 5.95 15 A ALA 62 -103.57 49.41 15 A LYS 82 52.10 13.38 15 A GLU 88 -171.99 147.91 15 A ASN 93 -104.62 79.72 16 A PRO 40 -69.84 5.69 16 A VAL 59 -63.85 7.48 16 A ALA 62 -103.11 50.05 16 A LYS 82 52.58 9.25 16 A ASN 93 -103.99 78.65 17 A VAL 59 -62.78 4.35 17 A ALA 62 -103.90 48.12 17 A LYS 82 51.77 14.72 18 A PHE 41 -115.41 -70.65 18 A ASN 51 -99.32 32.30 18 A VAL 59 -63.24 6.14 18 A ALA 62 -103.41 50.95 18 A LYS 82 52.41 10.45 18 A GLU 88 -172.10 146.72 19 A ASN 51 -99.20 31.34 19 A VAL 59 -62.92 6.61 19 A ALA 62 -105.02 54.44 19 A LYS 82 52.19 12.76 20 A PHE 41 -116.28 -70.78 20 A HIS 43 -65.60 0.06 20 A VAL 59 -63.18 5.67 20 A ALA 62 -102.99 47.92 20 A LYS 82 52.53 10.16 21 A PHE 41 -115.29 -71.53 21 A VAL 59 -63.88 7.78 21 A ALA 62 -103.50 51.68 21 A LYS 82 52.28 12.39 22 A PHE 41 -115.48 -70.56 22 A ASN 51 -99.81 31.87 22 A VAL 59 -63.79 7.78 22 A ALA 62 -104.10 54.07 22 A LYS 82 52.42 13.42 23 A CYS 32 -46.61 166.97 23 A PHE 41 -114.99 -70.51 23 A ASN 51 -99.49 33.11 23 A VAL 59 -66.49 24.49 23 A ALA 62 -101.69 57.30 23 A ALA 73 -151.52 89.83 23 A LYS 82 52.29 9.99 23 A GLU 88 -171.54 148.80 24 A PHE 41 -115.62 -72.43 24 A ASN 51 -99.64 33.88 24 A VAL 59 -63.81 7.41 24 A ALA 62 -104.05 52.37 24 A LYS 82 51.61 11.14 25 A PHE 41 -116.10 -70.63 25 A VAL 59 -63.69 7.17 25 A ALA 62 -103.49 53.07 25 A LYS 82 52.30 11.05 25 A ALA 92 -80.89 46.59 25 A ASN 93 -102.93 73.66 26 A PHE 41 -115.33 -72.59 26 A ASN 51 -99.29 32.77 26 A VAL 59 -63.30 6.07 26 A ALA 62 -103.16 50.40 26 A ALA 73 -152.17 89.14 26 A LYS 82 51.77 9.94 26 A GLU 98 -66.46 -70.24 27 A PHE 41 -115.39 -70.30 27 A ASN 51 -98.37 31.31 27 A VAL 59 -63.18 6.21 27 A ALA 62 -101.86 49.16 27 A ALA 73 -152.16 89.44 27 A LYS 82 52.40 9.80 27 A GLU 88 -172.66 146.37 28 A ASN 51 -99.18 32.11 28 A VAL 59 -62.95 4.95 28 A ALA 62 -103.91 51.43 28 A LYS 82 52.45 9.60 28 A ASN 93 -104.63 74.31 29 A PHE 41 -115.39 -70.09 29 A LEU 45 -59.94 -7.89 29 A VAL 59 -62.95 5.23 29 A ALA 62 -103.33 53.36 29 A LYS 82 51.71 14.53 30 A VAL 59 -63.54 6.34 30 A ALA 62 -102.53 50.68 30 A ALA 73 -151.95 88.38 30 A LYS 82 52.13 13.48 30 A ASN 93 -103.59 79.19 31 A HIS 43 -65.62 0.47 31 A ASN 51 -98.67 30.58 31 A VAL 59 -63.74 8.41 31 A ALA 62 -104.00 52.64 31 A LYS 82 51.79 10.30 31 A GLU 88 -172.11 148.15 32 A PHE 41 -115.46 -70.27 32 A ASN 51 -99.66 31.14 32 A VAL 59 -63.23 5.94 32 A ALA 62 -104.21 51.03 32 A LYS 82 51.62 10.98 32 A ALA 92 -79.75 49.88 32 A ASN 93 -104.15 75.14 33 A ILE 38 -95.34 30.59 33 A PHE 41 -116.35 -71.08 33 A HIS 43 -65.35 0.23 33 A VAL 59 -63.31 7.08 33 A ALA 62 -103.91 52.25 33 A LYS 82 52.50 13.62 33 A GLU 88 -171.67 147.07 33 A ASN 93 -104.36 74.89 34 A ASN 51 -99.19 32.06 34 A VAL 59 -63.35 6.35 34 A ALA 62 -103.97 54.45 34 A LYS 82 52.09 9.40 34 A GLU 88 -172.05 149.62 34 A ALA 92 -79.91 48.22 34 A ASN 93 -104.12 76.61 35 A CYS 32 -49.45 166.29 35 A PHE 41 -115.73 -70.41 35 A VAL 59 -62.83 4.93 35 A ALA 62 -101.57 53.83 35 A LYS 82 52.02 10.71 36 A PRO 40 -66.82 2.47 36 A ASN 51 -99.83 31.70 36 A VAL 59 -62.68 5.87 36 A ALA 62 -103.72 56.52 36 A LYS 82 51.62 12.81 36 A ASN 93 -104.46 78.72 37 A PHE 41 -115.28 -70.52 37 A VAL 59 -62.71 6.35 37 A ALA 62 -102.83 54.27 37 A LYS 82 52.28 16.54 37 A ASN 93 -103.61 74.39 38 A PHE 41 -115.22 -70.44 38 A ASN 51 -99.43 30.34 38 A VAL 59 -63.39 6.45 38 A ALA 62 -102.92 51.94 38 A LYS 82 53.47 19.31 38 A GLU 88 -171.50 148.62 39 A PHE 41 -115.28 -70.13 39 A ASN 51 -98.82 31.85 39 A VAL 59 -62.89 5.41 39 A ALA 62 -103.62 50.45 39 A LYS 82 52.74 9.18 40 A PRO 40 -69.90 6.51 40 A ASN 51 -99.15 31.74 40 A VAL 59 -62.95 6.00 40 A ALA 62 -103.62 50.28 40 A LYS 82 52.40 12.86 THE HIGH-RESOLUTION THREE-DIMENSIONAL SOLUTION STRUCTURES OF THE OXIDIZED AND REDUCED STATES OF HUMAN THIOREDOXIN 1 Y N 2 N N A SER 7 A SER 7 HELX_P A GLY 19 A GLY 19 1 1 13 A CYS 35 A CYS 35 HELX_P A LYS 39 A LYS 39 5 2 5 A SER 44 A SER 44 HELX_P A TYR 49 A TYR 49 1 3 6 A ALA 62 A ALA 62 HELX_P A ALA 69 A ALA 69 1 4 8 A ASN 93 A ASN 93 HELX_P A ASN 102 A ASN 102 1 5 10 disulf 2.022 A CYS 32 A SG CYS 32 1_555 A CYS 35 A SG CYS 35 1_555 ELECTRON TRANSPORT ELECTRON TRANSPORT A THR 74 A THR 74 1 A PRO 75 A PRO 75 -1.03 A THR 74 A THR 74 2 A PRO 75 A PRO 75 -1.07 A THR 74 A THR 74 3 A PRO 75 A PRO 75 -1.06 A THR 74 A THR 74 4 A PRO 75 A PRO 75 -1.27 A THR 74 A THR 74 5 A PRO 75 A PRO 75 -1.16 A THR 74 A THR 74 6 A PRO 75 A PRO 75 -1.20 A THR 74 A THR 74 7 A PRO 75 A PRO 75 -1.11 A THR 74 A THR 74 8 A PRO 75 A PRO 75 -1.02 A THR 74 A THR 74 9 A PRO 75 A PRO 75 -1.18 A THR 74 A THR 74 10 A PRO 75 A PRO 75 -1.08 A THR 74 A THR 74 11 A PRO 75 A PRO 75 -1.09 A THR 74 A THR 74 12 A PRO 75 A PRO 75 -1.07 A THR 74 A THR 74 13 A PRO 75 A PRO 75 -1.07 A THR 74 A THR 74 14 A PRO 75 A PRO 75 -1.08 A THR 74 A THR 74 15 A PRO 75 A PRO 75 -1.05 A THR 74 A THR 74 16 A PRO 75 A PRO 75 -1.01 A THR 74 A THR 74 17 A PRO 75 A PRO 75 -1.11 A THR 74 A THR 74 18 A PRO 75 A PRO 75 -1.11 A THR 74 A THR 74 19 A PRO 75 A PRO 75 -0.98 A THR 74 A THR 74 20 A PRO 75 A PRO 75 -1.02 A THR 74 A THR 74 21 A PRO 75 A PRO 75 -1.14 A THR 74 A THR 74 22 A PRO 75 A PRO 75 -1.03 A THR 74 A THR 74 23 A PRO 75 A PRO 75 -1.12 A THR 74 A THR 74 24 A PRO 75 A PRO 75 -1.11 A THR 74 A THR 74 25 A PRO 75 A PRO 75 -1.06 A THR 74 A THR 74 26 A PRO 75 A PRO 75 -1.06 A THR 74 A THR 74 27 A PRO 75 A PRO 75 -1.05 A THR 74 A THR 74 28 A PRO 75 A PRO 75 -1.10 A THR 74 A THR 74 29 A PRO 75 A PRO 75 -1.12 A THR 74 A THR 74 30 A PRO 75 A PRO 75 -1.03 A THR 74 A THR 74 31 A PRO 75 A PRO 75 -1.10 A THR 74 A THR 74 32 A PRO 75 A PRO 75 -1.08 A THR 74 A THR 74 33 A PRO 75 A PRO 75 -0.91 A THR 74 A THR 74 34 A PRO 75 A PRO 75 -0.97 A THR 74 A THR 74 35 A PRO 75 A PRO 75 -1.17 A THR 74 A THR 74 36 A PRO 75 A PRO 75 -1.07 A THR 74 A THR 74 37 A PRO 75 A PRO 75 -1.09 A THR 74 A THR 74 38 A PRO 75 A PRO 75 -0.99 A THR 74 A THR 74 39 A PRO 75 A PRO 75 -1.17 A THR 74 A THR 74 40 A PRO 75 A PRO 75 -1.16 THIO_HUMAN UNP 1 1 P10599 VKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFK KGQKVGEFSGANKEKLEATINELV 1 104 1TRU 2 105 P10599 A 1 2 105 1 CYS conflict ALA 62 1TRU A P10599 UNP 61 62 1 CYS conflict ALA 69 1TRU A P10599 UNP 68 69 1 CYS conflict ALA 73 1TRU A P10599 UNP 72 73 1 MET conflict THR 74 1TRU A P10599 UNP 73 74 5 parallel parallel anti-parallel anti-parallel A VAL 2 A VAL 2 A ILE 5 A ILE 5 A ILE 53 A ILE 53 A ASP 58 A ASP 58 A VAL 23 A VAL 23 A SER 28 A SER 28 A THR 76 A THR 76 A LYS 81 A LYS 81 A GLN 84 A GLN 84 A SER 90 A SER 90 1 P 1